Paediatric ED BiPAP continuous quality improvement programme with patient analysis: 2005-2013

Thomas Abramo, Abby Williams, Samaiya Mushtaq, Mark Meredith, Rawle Sepaule, Kristen Crossman, Cheryl Burney Jones, Suzanne Godbold, Zhuopei Hu, Todd Nick

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective In paediatric moderate-to-severe asthmatics, there is significant bronchospasm, airway obstruction, air trapping causing severe hyperinflation with more positive intraplural pressure preventing passive air movement. These effects cause an increased respiratory rate (RR), less airflow and shortened inspiratory breath time. In certain asthmatics, aerosols are ineffective due to their inadequate ventilation. Bilevel positive airway pressure (BiPAP) in acute paediatric asthmatics can be an effective treatment. BiPAP works by unloading fatigued inspiratory muscles, a direct bronchodilation effect, offsetting intrinsic PEEP and recruiting collapsed alveoli that reduces the patient's work of breathing and achieves their total lung capacity quicker. Unfortunately, paediatric emergency department (PED) BiPAP is underused and quality analysis is non-existent. A PED BiPAP Continuous Quality Improvement Program (CQIP) from 2005 to 2013 was evaluated using descriptive analytics for the primary outcomes of usage, safety, BiPAP settings, therapeutics and patient disposition. Interventions PED BiPAP CQIP descriptive analytics. Setting Academic PED. Participants 1157 patients. Interventions A PED BiPAP CQIP from 2005 to 2013 for the usage, safety, BiPAP settings, therapeutic response parameters and patient disposition was evaluated using descriptive analytics. Primary and secondary outcomes Safety, usage, compliance, therapeutic response parameters, BiPAP settings and patient disposition. Results 1157 patients had excellent compliance without complications. Only 6 (0.5%) BiPAP patients were intubated. BiPAP median settings: IPAP 18 (16,20) cm H2O range 12-28; EPAP 8 cm H2O (8,8) range 6-10; inspiratory-to-expiratory time (I:E) ratio 1.75 (1.5,1.75). Pediatric Asthma Severity score and RR decreased (p<0.001) while tidal volume increased (p<0.001). Patient disposition: 325 paediatric intensive care units (PICU), 832 wards, with 52 of these PED ward patients were discharged home with only 2 hours of PED BiPAP with no returning to the PED within 72 hours. Conclusions BiPAP is a safe and effective therapeutic option for paediatric patients with asthma presenting to a PED or emergency department. This BiPAP CQIP showed significant patient compliance, no complications, improved therapeutics times, very low intubations and decreased PICU admissions. CQIP analysis demonstrated that using a higher IPAP, low EPAP with longer I:E optimises the patient's BiPAP settings and showed a significant improvement in PAS, RR and tidal volume. BiPAP should be considered as an early treatment in the PED severe or non-responsive moderate asthmatics.

Original languageEnglish (US)
Article numbere011845
JournalBMJ Open
Volume7
Issue number1
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Continuous Positive Airway Pressure
Quality Improvement
Hospital Emergency Service
Pediatrics
Pressure
Respiratory Rate
Pediatric Intensive Care Units
Tidal Volume
Safety
Therapeutics
Compliance
Intrinsic Positive-Pressure Respiration
Asthma
Air Movements
Work of Breathing
Total Lung Capacity
Bronchial Spasm
Airway Obstruction
Patient Compliance
Aerosols

Keywords

  • BiPAP
  • BiPAP, Status Asthmaticus, Asthma, Pediatric Emergency Department, Continuous Quality Improvement Program (CQIP) Noninvasive Pos
  • Continuous Quality Improvement Program (CQIP)
  • Noninvasive Positive Pressure Ventilation
  • Status Asthma

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Abramo, T., Williams, A., Mushtaq, S., Meredith, M., Sepaule, R., Crossman, K., ... Nick, T. (2017). Paediatric ED BiPAP continuous quality improvement programme with patient analysis: 2005-2013. BMJ Open, 7(1), [e011845]. https://doi.org/10.1136/bmjopen-2016-011845

Paediatric ED BiPAP continuous quality improvement programme with patient analysis : 2005-2013. / Abramo, Thomas; Williams, Abby; Mushtaq, Samaiya; Meredith, Mark; Sepaule, Rawle; Crossman, Kristen; Burney Jones, Cheryl; Godbold, Suzanne; Hu, Zhuopei; Nick, Todd.

In: BMJ Open, Vol. 7, No. 1, e011845, 01.01.2017.

Research output: Contribution to journalArticle

Abramo, T, Williams, A, Mushtaq, S, Meredith, M, Sepaule, R, Crossman, K, Burney Jones, C, Godbold, S, Hu, Z & Nick, T 2017, 'Paediatric ED BiPAP continuous quality improvement programme with patient analysis: 2005-2013', BMJ Open, vol. 7, no. 1, e011845. https://doi.org/10.1136/bmjopen-2016-011845
Abramo, Thomas ; Williams, Abby ; Mushtaq, Samaiya ; Meredith, Mark ; Sepaule, Rawle ; Crossman, Kristen ; Burney Jones, Cheryl ; Godbold, Suzanne ; Hu, Zhuopei ; Nick, Todd. / Paediatric ED BiPAP continuous quality improvement programme with patient analysis : 2005-2013. In: BMJ Open. 2017 ; Vol. 7, No. 1.
@article{d9402b3c05364fcfa99ceea1db26c7a9,
title = "Paediatric ED BiPAP continuous quality improvement programme with patient analysis: 2005-2013",
abstract = "Objective In paediatric moderate-to-severe asthmatics, there is significant bronchospasm, airway obstruction, air trapping causing severe hyperinflation with more positive intraplural pressure preventing passive air movement. These effects cause an increased respiratory rate (RR), less airflow and shortened inspiratory breath time. In certain asthmatics, aerosols are ineffective due to their inadequate ventilation. Bilevel positive airway pressure (BiPAP) in acute paediatric asthmatics can be an effective treatment. BiPAP works by unloading fatigued inspiratory muscles, a direct bronchodilation effect, offsetting intrinsic PEEP and recruiting collapsed alveoli that reduces the patient's work of breathing and achieves their total lung capacity quicker. Unfortunately, paediatric emergency department (PED) BiPAP is underused and quality analysis is non-existent. A PED BiPAP Continuous Quality Improvement Program (CQIP) from 2005 to 2013 was evaluated using descriptive analytics for the primary outcomes of usage, safety, BiPAP settings, therapeutics and patient disposition. Interventions PED BiPAP CQIP descriptive analytics. Setting Academic PED. Participants 1157 patients. Interventions A PED BiPAP CQIP from 2005 to 2013 for the usage, safety, BiPAP settings, therapeutic response parameters and patient disposition was evaluated using descriptive analytics. Primary and secondary outcomes Safety, usage, compliance, therapeutic response parameters, BiPAP settings and patient disposition. Results 1157 patients had excellent compliance without complications. Only 6 (0.5{\%}) BiPAP patients were intubated. BiPAP median settings: IPAP 18 (16,20) cm H2O range 12-28; EPAP 8 cm H2O (8,8) range 6-10; inspiratory-to-expiratory time (I:E) ratio 1.75 (1.5,1.75). Pediatric Asthma Severity score and RR decreased (p<0.001) while tidal volume increased (p<0.001). Patient disposition: 325 paediatric intensive care units (PICU), 832 wards, with 52 of these PED ward patients were discharged home with only 2 hours of PED BiPAP with no returning to the PED within 72 hours. Conclusions BiPAP is a safe and effective therapeutic option for paediatric patients with asthma presenting to a PED or emergency department. This BiPAP CQIP showed significant patient compliance, no complications, improved therapeutics times, very low intubations and decreased PICU admissions. CQIP analysis demonstrated that using a higher IPAP, low EPAP with longer I:E optimises the patient's BiPAP settings and showed a significant improvement in PAS, RR and tidal volume. BiPAP should be considered as an early treatment in the PED severe or non-responsive moderate asthmatics.",
keywords = "BiPAP, BiPAP, Status Asthmaticus, Asthma, Pediatric Emergency Department, Continuous Quality Improvement Program (CQIP) Noninvasive Pos, Continuous Quality Improvement Program (CQIP), Noninvasive Positive Pressure Ventilation, Status Asthma",
author = "Thomas Abramo and Abby Williams and Samaiya Mushtaq and Mark Meredith and Rawle Sepaule and Kristen Crossman and {Burney Jones}, Cheryl and Suzanne Godbold and Zhuopei Hu and Todd Nick",
year = "2017",
month = "1",
day = "1",
doi = "10.1136/bmjopen-2016-011845",
language = "English (US)",
volume = "7",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "1",

}

TY - JOUR

T1 - Paediatric ED BiPAP continuous quality improvement programme with patient analysis

T2 - 2005-2013

AU - Abramo, Thomas

AU - Williams, Abby

AU - Mushtaq, Samaiya

AU - Meredith, Mark

AU - Sepaule, Rawle

AU - Crossman, Kristen

AU - Burney Jones, Cheryl

AU - Godbold, Suzanne

AU - Hu, Zhuopei

AU - Nick, Todd

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Objective In paediatric moderate-to-severe asthmatics, there is significant bronchospasm, airway obstruction, air trapping causing severe hyperinflation with more positive intraplural pressure preventing passive air movement. These effects cause an increased respiratory rate (RR), less airflow and shortened inspiratory breath time. In certain asthmatics, aerosols are ineffective due to their inadequate ventilation. Bilevel positive airway pressure (BiPAP) in acute paediatric asthmatics can be an effective treatment. BiPAP works by unloading fatigued inspiratory muscles, a direct bronchodilation effect, offsetting intrinsic PEEP and recruiting collapsed alveoli that reduces the patient's work of breathing and achieves their total lung capacity quicker. Unfortunately, paediatric emergency department (PED) BiPAP is underused and quality analysis is non-existent. A PED BiPAP Continuous Quality Improvement Program (CQIP) from 2005 to 2013 was evaluated using descriptive analytics for the primary outcomes of usage, safety, BiPAP settings, therapeutics and patient disposition. Interventions PED BiPAP CQIP descriptive analytics. Setting Academic PED. Participants 1157 patients. Interventions A PED BiPAP CQIP from 2005 to 2013 for the usage, safety, BiPAP settings, therapeutic response parameters and patient disposition was evaluated using descriptive analytics. Primary and secondary outcomes Safety, usage, compliance, therapeutic response parameters, BiPAP settings and patient disposition. Results 1157 patients had excellent compliance without complications. Only 6 (0.5%) BiPAP patients were intubated. BiPAP median settings: IPAP 18 (16,20) cm H2O range 12-28; EPAP 8 cm H2O (8,8) range 6-10; inspiratory-to-expiratory time (I:E) ratio 1.75 (1.5,1.75). Pediatric Asthma Severity score and RR decreased (p<0.001) while tidal volume increased (p<0.001). Patient disposition: 325 paediatric intensive care units (PICU), 832 wards, with 52 of these PED ward patients were discharged home with only 2 hours of PED BiPAP with no returning to the PED within 72 hours. Conclusions BiPAP is a safe and effective therapeutic option for paediatric patients with asthma presenting to a PED or emergency department. This BiPAP CQIP showed significant patient compliance, no complications, improved therapeutics times, very low intubations and decreased PICU admissions. CQIP analysis demonstrated that using a higher IPAP, low EPAP with longer I:E optimises the patient's BiPAP settings and showed a significant improvement in PAS, RR and tidal volume. BiPAP should be considered as an early treatment in the PED severe or non-responsive moderate asthmatics.

AB - Objective In paediatric moderate-to-severe asthmatics, there is significant bronchospasm, airway obstruction, air trapping causing severe hyperinflation with more positive intraplural pressure preventing passive air movement. These effects cause an increased respiratory rate (RR), less airflow and shortened inspiratory breath time. In certain asthmatics, aerosols are ineffective due to their inadequate ventilation. Bilevel positive airway pressure (BiPAP) in acute paediatric asthmatics can be an effective treatment. BiPAP works by unloading fatigued inspiratory muscles, a direct bronchodilation effect, offsetting intrinsic PEEP and recruiting collapsed alveoli that reduces the patient's work of breathing and achieves their total lung capacity quicker. Unfortunately, paediatric emergency department (PED) BiPAP is underused and quality analysis is non-existent. A PED BiPAP Continuous Quality Improvement Program (CQIP) from 2005 to 2013 was evaluated using descriptive analytics for the primary outcomes of usage, safety, BiPAP settings, therapeutics and patient disposition. Interventions PED BiPAP CQIP descriptive analytics. Setting Academic PED. Participants 1157 patients. Interventions A PED BiPAP CQIP from 2005 to 2013 for the usage, safety, BiPAP settings, therapeutic response parameters and patient disposition was evaluated using descriptive analytics. Primary and secondary outcomes Safety, usage, compliance, therapeutic response parameters, BiPAP settings and patient disposition. Results 1157 patients had excellent compliance without complications. Only 6 (0.5%) BiPAP patients were intubated. BiPAP median settings: IPAP 18 (16,20) cm H2O range 12-28; EPAP 8 cm H2O (8,8) range 6-10; inspiratory-to-expiratory time (I:E) ratio 1.75 (1.5,1.75). Pediatric Asthma Severity score and RR decreased (p<0.001) while tidal volume increased (p<0.001). Patient disposition: 325 paediatric intensive care units (PICU), 832 wards, with 52 of these PED ward patients were discharged home with only 2 hours of PED BiPAP with no returning to the PED within 72 hours. Conclusions BiPAP is a safe and effective therapeutic option for paediatric patients with asthma presenting to a PED or emergency department. This BiPAP CQIP showed significant patient compliance, no complications, improved therapeutics times, very low intubations and decreased PICU admissions. CQIP analysis demonstrated that using a higher IPAP, low EPAP with longer I:E optimises the patient's BiPAP settings and showed a significant improvement in PAS, RR and tidal volume. BiPAP should be considered as an early treatment in the PED severe or non-responsive moderate asthmatics.

KW - BiPAP

KW - BiPAP, Status Asthmaticus, Asthma, Pediatric Emergency Department, Continuous Quality Improvement Program (CQIP) Noninvasive Pos

KW - Continuous Quality Improvement Program (CQIP)

KW - Noninvasive Positive Pressure Ventilation

KW - Status Asthma

UR - http://www.scopus.com/inward/record.url?scp=85010417499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010417499&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2016-011845

DO - 10.1136/bmjopen-2016-011845

M3 - Article

C2 - 28093429

AN - SCOPUS:85010417499

VL - 7

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 1

M1 - e011845

ER -